China May Use COVID-19 Vaccine From November


The COVID-19 vaccine may be available for use by the general public in the month of November in China, a Reuters report said.

The report quoted the China Centre for Disease Control and Prevention (CDC) chief biosafety expert Guizhen Wu as saying that the “Phase 3 clinical trials were proceeding smoothly.”

It must be mentioned that China has four COVID-19 vaccines in the final stage of clinical trials.

While three vaccines are being developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech under the state’s emergency use programme, the fourth vaccine is being developed by CanSino Biologics, which was approved for use by the Chinese military in June.

You might also like